TORL BioTherapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
April 13, 2023
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$158,000,000
Company Info
Founders
David Licata
Company Description
TORL BioTherapeutics LLC is a clinical-stage biopharmaceutical company with the objective of developing novel, antibody-based therapeutics to transform the lives of cancer patients. Its lead candidate, TORL-1-23, is a CLDN6-directed ADC developed for patients across multiple cancer types.
Market
Cancer therapeutics
Location
Los Angeles, CA, USA
Coinvestors
Alexandria Venture Investments, Bristol Myers Squibb, Cowen Healthcare Investments, Deep Track Capital, Goldman Sachs Asset Management, Moore Strategic Ventures, OCV Partners, Perceptive, Xontogeny Venture Fund, Vertex Ventures
Links
Back to Home Back to Biopharmaceuticals Deals View Funding Announcement